Optiver Holding’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.86M Buy
204,956
+153,863
+301% +$4.88M ﹤0.01% 450
2026
Q1
$1.61M Sell
51,093
-430,851
-89% -$13.6M ﹤0.01% 519
2025
Q4
$14.2M Sell
481,944
-984,770
-67% -$27.4M 0.01% 288
2025
Q3
$37M Buy
1,466,714
+803,280
+121% +$19.6M 0.01% 165
2025
Q2
$15.9M Buy
+663,434
New +$15.4M 0.01% 161
2023
Q4
– Sell
-161,437
Closed -$6.01M – 577
2023
Q3
$6.01M Sell
161,437
-41,956
-21% -$1.6M ﹤0.01% 309
2023
Q2
$7.95M Sell
203,393
-21,031
-9% -$824K 0.01% 282
2023
Q1
$8.19M Buy
+224,424
New +$7.08M 0.01% 297

Other funds holding RTO

Optiver Holding's RTO Position: Q2 2026 in Review

Optiver Holding increased its Rentokil (RTO) stake by 301% in Q2 2026, buying an estimated $4.88M and bringing the position to 204,956 shares worth $5.86M. The position accounts for ﹤0.01% of the portfolio, ranked #450.

Optiver Holding first reported a position in RTO in Q1 2023 and has held it in 8 quarters since. The position peaked at $37M in Q3 2025. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Optiver Holding held 204,956 shares of Rentokil worth $5.86M as of Q2 2026.
  • Optiver Holding bought 153,863 Rentokil shares in Q2 2026, an estimated $4.88M.
  • Rentokil made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #450 holding.
  • Optiver Holding first reported a position in Rentokil in Q1 2023 and has held it in 8 quarters since.
  • Optiver Holding's Rentokil position peaked at $37M in Q3 2025.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.